Technical Analysis for CBLL - CeriBell, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | N/A | N/A | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
New Downtrend | Bearish | 0.00% | |
Hot IPO Pullback | Bullish Swing Setup | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Inside Day | Range Contraction | -3.70% | |
Down 3 Days in a Row | Weakness | -3.70% | |
20 DMA Support | Bullish | -4.84% |
Alert | Time |
---|---|
Gap Up Closed | about 10 hours ago |
10 DMA Resistance | about 10 hours ago |
Outside Day | about 10 hours ago |
Down 3% | about 10 hours ago |
Fell Below Previous Day's Low | about 10 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 11/12/2024
CeriBell, Inc. Description
Ceribell focuses on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective. The company creates and validates an FDA cleared instant EEG system that does not require an EEG technologist or specialist interpreter, which allows for faster results and clinical decision-making. The Ceribell EEG System can be set up by any healthcare provider in 6 minutes and offers a proprietary Brain Stethoscope function that dramatically simplifies interpretation of EEG results by converting brainwaves to sound so seizures can be detected by listening. Earlier diagnosis and focused treatment for patients with seizures, including non-convulsive seizures that can only be diagnosed with EEG, can significantly lower mortality, secondary brain injury, length of stay, and risk of complications.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: FDA Neurophysiology Neurotechnology Electroencephalography Electrophysiology Seizure Electrodiagnosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 29.53 |
52 Week Low | 23.0 |
Average Volume | 224,792 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 0.00 |
20-Day Moving Average | 27.06 |
10-Day Moving Average | 27.79 |
Average True Range | 1.32 |
RSI (14) | 49.49 |
ADX | 31.44 |
+DI | 16.57 |
-DI | 17.33 |
Chandelier Exit (Long, 3 ATRs) | 25.58 |
Chandelier Exit (Short, 3 ATRs) | 28.97 |
Upper Bollinger Bands | 29.07 |
Lower Bollinger Band | 25.04 |
Percent B (%b) | 0.37 |
BandWidth | 14.90 |
MACD Line | 0.68 |
MACD Signal Line | 0.61 |
MACD Histogram | 0.0693 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 29.94 | ||||
Resistance 3 (R3) | 30.30 | 29.52 | 29.37 | ||
Resistance 2 (R2) | 29.52 | 28.66 | 29.34 | 29.18 | |
Resistance 1 (R1) | 28.03 | 28.12 | 27.64 | 27.67 | 28.99 |
Pivot Point | 27.25 | 27.25 | 27.06 | 27.07 | 27.25 |
Support 1 (S1) | 25.76 | 26.39 | 25.37 | 25.40 | 24.07 |
Support 2 (S2) | 24.98 | 25.85 | 24.80 | 23.88 | |
Support 3 (S3) | 23.49 | 24.98 | 23.69 | ||
Support 4 (S4) | 23.13 |